Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study
Title:
Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study
Author:
Asare, Kwabena Sookrajh, Yukteshwar van der Molen, Johan Khubone, Thokozani Lewis, Lara Lessells, Richard J Naidoo, Kogieleum Sosibo, Phelelani van Heerden, Rosemary Garrett, Nigel Dorward, Jienchi
Appeared in:
The Lancet global health
Paging:
Volume 12 () nr. 2 pages e282-e291
Year:
2024
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license